.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Novartis
UBS
Mallinckrodt
Chubb
Julphar
Merck
Daiichi Sankyo
Colorcon
Fuji

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016807

« Back to Dashboard

NDA 016807 describes THYROLAR-5, which is a drug marketed by Forest Labs and is included in one NDA. It is available from one supplier. Additional details are available on the THYROLAR-5 profile page.

The generic ingredient in THYROLAR-5 is liotrix (t4;t3). One supplier is listed for this compound. Additional details are available on the liotrix (t4;t3) profile page.

Summary for 016807

Tradename:6
Applicant:1
Ingredient:1
Patents:0

Pharmacology for NDA: 016807

Suppliers and Packaging for NDA: 016807

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THYROLAR-0.25 liotrix (t4;t3) TABLET;ORAL 016807 NDA Forest Laboratories, Inc 0456-0040 0456-0040-01 100 TABLET in 1 BOTTLE (0456-0040-01)
THYROLAR-0.25 liotrix (t4;t3) TABLET;ORAL 016807 NDA Forest Laboratories, Inc 0456-0045 0456-0045-01 100 TABLET in 1 BOTTLE (0456-0045-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.0125MG;0.0031MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.1MG;0.025MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.15MG;0.0375MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
UBS
Farmers Insurance
US Department of Justice
AstraZeneca
Accenture
Deloitte
Harvard Business School
Cantor Fitzgerald
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot